Old Web
English
Sign In
Acemap
>
authorDetail
>
Kazuto Mishima
Kazuto Mishima
Asahikawa Medical University
Nivolumab
Medicine
Immunogenicity
Pathology
Antibody
3
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Real-World Nivolumab Wastage and Leftover Drug Stability Assessment to Facilitate Drug Vial Optimization for Cost Savings.
2020
Masahide Fukudo
Ryota Ishikawa
Kazuto Mishima
Takashi Ono
Seiji Matsumoto
Yoshikazu Tasaki
Show All
Source
Cite
Save
Citations (1)
Pharmacists' Interventions in the Infection Control Team Reduce Prophylactic Intravenous Antibiotics in Cataract Surgery
2019
Japanese Journal of Pharmaceutical Health Care and Sciences
Ko-ichi Yoshida
Joe Yamamoto
Ko-ichi Ohtaki
Hitomi Tsuzuki
Atsushi Takahashi
Masatoshi Kando
Shinya Iida
Sachiko Kasamo
Takayuki Manabe
Kazuto Mishima
Takashi Ono
Masahide Fukudo
Toshio Awaya
Yoshikazu Tasaki
Show All
Source
Cite
Save
Citations (0)
Long-term follow-up of pharmacokinetics (PK) and immunogenicity of the anti–PD-1 antibodies nivolumab (Nivo) and pembrolizumab (Pembro) in real-world practice.
2019
Journal of Clinical Oncology
Masahide Fukudo
Kazuto Mishima
Norihisa Kimura
Yuichiro Shinden
Takaaki Sasaki
Shunsuke Okumura
Yoshinobu Ohsaki
Jiro Uehara
Akemi Yamamoto
Gaku Tamaki
Hidehiro Kakizaki
Kan Kishibe
Miki Takahara
Tatsuya Hayashi
Yasuaki Harabuchi
Tatsuya Shonaka
Kimiharu Hasegawa
Takashi Ono
Yoshikazu Tasaki
Show All
Source
Cite
Save
Citations (0)
1